• Join
  • Login
  • Contact

Search abstracts

Fixed dose combination products for chronic diseases, AIDS, TB and malaria: benefits and regulatory challenges

  • At: Salvadore (Brazil) (2006)
  • Type: Presentation
  • By: WANING, Brenda (Boston University, International Health, Cambridge, United States of America)
  • Abstract:

    There has been much discussion on the role of fixed-dose combination (FDC) medicines for the treatment of several conditions, specifically: cardiovascular disease, hypertension, diabetes, HIV/AIDS, tuberculosis, and malaria. National and international organizations including WHO, UNAIDS, US DHHS, and others have made formal statements in support


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses